You are here: Industry Insights > cancer

News List

Merck and Pfizer trial cancer combination with Australia’s Immutep pharmaphorum
September 27, 2018
Australian biotech Immutep has begun a clinical trial partnership with Germany’s Merck KGaA and Pfizer to develop a new cancer immunotherapy combination therapy.
Daiichi to test cancer drug combo pharmatimes
September 21, 2018
Daiichi Sankyo has entered into a clinical trial collaboration agreement with a subsidiary of MSD to evaluate a potential new combination therapy for breast or lung cancers.
FDA approves AstraZeneca’s Lumoxiti for hairy cell leukaemia (HCL) pharmafile
September 20, 2018
AstraZeneca’s Lumoxiti has been approved for use for the treatment of relapsed or refractory hairy cell leukemia (HCL)in adults who have had at least two prior therapies for the disease.
Cancer Research UK announces new £14m research hub in London pharmafile
September 20, 2018
Cancer Research UK has announced a £14 million investment to build a new hub in London for cancer research and treatment to create “a global centre...
CR UK invests £14m in London cancer biotherapeutics hub pharmatimes
September 20, 2018
Cancer Research UK is investing some £14 million into transforming the city of London into a “world-leading hub for cancer biotherapeutics”.
Boehringer buys ViraTherapeutics pharmatimes
September 18, 2018
Boehringer Ingelheim has exercised an option to acquire all shares of oncolytic virus company ViraTherapeutics.
NHS summer performance hits new lows pharmatimes
September 18, 2018
Alarm bells over the NHS’ ability to cope with looming winter pressures are ringing again after some aspects of service performance...
Is cancer fundraising fuelling deceit? europeanpharmaceuticalreview
September 18, 2018
Researchers questioned whether cancer crowdfunding elicits deception, especially when offering patients treatments with no scientific backing…
No Apparent Short-Term Cancer Risk From Recalled Valsartan drugs
September 14, 2018
Users of valsartan contaminated with N-nitrosodimethylamine (NDMA) seem not to have increased cancer risk, according to a study published online Sept. 12 in The BMJ.
At Least 15 Men Near Ground Zero Have Breast Cancer drugs
September 13, 2018
At least 15 men who worked near Ground Zero after the 9/11 attacks have been diagnosed with breast cancer, a New York City law firm claims.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page